The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens

被引:1281
|
作者
Wyatt, R
Sodroski, J [1 ]
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol AIDS,Dept Pathol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
关键词
D O I
10.1126/science.280.5371.1884
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The human immunodeficiency virus-type 1 (HIV-1) envelope glycoproteins interact with receptors on the target cell and mediate virus entry by fusing the viral and cell membranes. The structure of the envelope glycoproteins has evolved to fulfill these functions while evading the neutralizing antibody response. An understanding of the viral strategies for immune evasion should guide attempts to improve the immunogenicity of the HIV-1envelope glycoproteins and, ultimately, aid in HIV-1vaccine development.
引用
收藏
页码:1884 / 1888
页数:5
相关论文
共 50 条
  • [41] Development of Germline-Specific HIV-1 Envelope Immunogens Using Directed Molecular Evolution
    Hoot, S.
    Gudavalli, S.
    Muranaka, J.
    Kutach, A.
    Narayan, K. M.
    Lie, Y.
    Wrin, T.
    Whalen, R. G.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A149 - A149
  • [42] Enhancing anti-viral neutralization response to immunization with HIV-1 envelope glycoprotein immunogens
    Ahmed, Shamim
    Parthasarathy, Durgadevi
    Newhall, Rachael
    Picard, Tashina
    Aback, Morgainne
    Ratnapriya, Sneha
    Arndt, William
    Vega-Rodriguez, Widaliz
    Kirk, Natalie M.
    Liang, Yuying
    Herschhorn, Alon
    [J]. NPJ VACCINES, 2023, 8 (01)
  • [43] Enhancing anti-viral neutralization response to immunization with HIV-1 envelope glycoprotein immunogens
    Shamim Ahmed
    Durgadevi Parthasarathy
    Rachael Newhall
    Tashina Picard
    Morgainne Aback
    Sneha Ratnapriya
    William Arndt
    Widaliz Vega-Rodriguez
    Natalie M. Kirk
    Yuying Liang
    Alon Herschhorn
    [J]. npj Vaccines, 8
  • [44] Factors limiting the immunogenicity of HIV-1 gp120 envelope glycoproteins
    Grundner, C
    Pancera, M
    Kang, JM
    Koch, M
    Sodroski, J
    Wyatt, R
    [J]. VIROLOGY, 2004, 330 (01) : 233 - 248
  • [45] INHIBITORY INFLUENCES OF ENVELOPE GLYCOPROTEINS OF HIV-1 ON NORMAL IMMUNE-RESPONSES
    CHIRMULE, N
    KALYANARAMAN, V
    OYAIZU, N
    PAHWA, S
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1988, 1 (05): : 425 - 430
  • [46] Immunogenicity of Oligomeric gp41 Immunogens Exposing the MPER of HIV-1 Envelope Glycoprotein
    Weiss, C.
    Vassell, R.
    Dey, A.
    He, Y.
    Sun, Y.
    Srivastava, I.
    Barnett, S.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A152 - A152
  • [47] DEFINITION OF A MULTISTEP CASCADE IN SYNCYTIA FORMATION MEDIATED BY HIV-1 ENVELOPE GLYCOPROTEINS
    BUGELSKI, PJ
    FU, YK
    HART, TK
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 187 - 187
  • [48] Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
    Gnanakaran, S.
    Daniels, Marcus G.
    Bhattacharya, Tanmoy
    Lapedes, Alan S.
    Sethi, Anurag
    Li, Ming
    Tang, Haili
    Greene, Kelli
    Gao, Hongmei
    Haynes, Barton F.
    Cohen, Myron S.
    Shaw, George M.
    Seaman, Michael S.
    Kumar, Amit
    Gao, Feng
    Montefiori, David C.
    Korber, Bette
    [J]. PLOS COMPUTATIONAL BIOLOGY, 2010, 6 (10)
  • [49] Molecular motions of human HIV-1 gp120 envelope glycoproteins
    Shu-Qun Liu
    Shi-Xi Liu
    Yun-Xin Fu
    [J]. Journal of Molecular Modeling, 2008, 14 : 857 - 870
  • [50] Genotypic and phenotypic analyses of brain-derived HIV-1 envelope glycoproteins
    Waszkiewicz, Anna
    Patel, Shailja
    Querido, Bianca
    Martin-Garcia, Julio
    [J]. JOURNAL OF NEUROVIROLOGY, 2006, 12 : 89 - 89